Abstract
Health crises in the pandemic context, tied to infectious diseases, require rapid biotechnology solutions to reduce transmissibility, proposing virucidal products (which inactivate viruses), treatment methods, vaccines, epidemiological surveillance, actions and instructions for public policies. The dramatic pandemic of COVID-19 caused by SARS-CoV-2 has enhanced the importance of virucida…